Stocks · Health care · Pharmaceutical Preparations

Biohaven Ltd.

BHVN Clue Score30

United States Fiscal year ends December CIK 0001935979 Results filed 29 Oct 2026

Add to watchlist

What the insiders did Net buying

By person

13 insiders · 100 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

John W Childs

Director

$95.36M (20)

—

+$95.36M

11,345,155

7.51%

$96.61M

+787.6%

Vlad Coric

Chief Executive Officer

$37.49M (19)

—

+$37.49M

2,544,514

1.68%

$21.67M

—

Gregory Bailey

Director

$9.24M (7)

—

+$9.24M

2,020,071

1.34%

$17.20M

—

Matthew Buten

Chief Financial Officer

$2.00M (2)

—

+$2.00M

195,652

0.1295%

$1.67M

+6,584%

Bruce Car

Chief Scientific Officer

$1.01M (1)

—

+$1.01M

37,715

0.0250%

$321.18K

+1,189%

Irina Antonijevic

Director

—

$459.66K (1) scheduled

−$459.66K

2,535

0.0017%

$21.59K

—

George C. Clark

VP, Chief Accounting Officer

$144.77K (1)

—

+$144.77K

86,978

0.0576%

$740.70K

+29.4%

Julia P Gregory

Director

$99.99K (1)

—

+$99.99K

25,665

0.0170%

$218.56K

—

Kimberly Gentile

SVP, Clinical Operations

—

—

—

99,557

0.0659%

$847.82K

—

Kishan Mehta

Director

—

—

—

22,662

0.0150%

$192.99K

—

Robert J Hugin

Director

—

—

—

19,486

0.0129%

$165.94K

—

Michael Thomas Heffernan

Director

—

—

—

19,370

0.0128%

$164.95K

—

Biohaven Pharmaceutical Holding Co Ltd. entity

10% owner

—

—

—

0

0.0000%

$0.00

—